Apeiron was founded in 2009 to bring Nobel prize winning olefin methatesis technology to the chemical industry and demonstrate its potential as a powerful yet cost-efficient and sustainable alternative to the well-established catalytic transformations. We thrive on helping our partners elevate their chemical processes by developing robust solutions and providing end-to-end olefin metathesis services.

Registered Capital:  

Registered Address:  

Company Type:  MPR

Business Scope: